Qingdao Haier Biomedical Co Ltd Capital Reinvestment Ratio
Qingdao Haier Biomedical Co Ltd capital reinvestment ratio. Qingdao Haier Biomedical Co Ltd (688139) has a Capital Reinvestment Ratio of 7.36x as of June 2023, meaning it reinvests 7% of its operating cash flow (CN¥7.33 Million) in capital expenditures (CN¥53.93 Million). Check cash flow reinvestment rate of Qingdao Haier Biomedical Co Ltd to assess the company's total reinvestment commitment from operating cash flow.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of Qingdao Haier Biomedical Co Ltd (2016–2025)
Capital reinvestment ratio of Qingdao Haier Biomedical Co Ltd from 2016 to 2025. This chart tracks Qingdao Haier Biomedical Co Ltd's Capital Reinvestment Ratio across 10 annual periods. Also explore net asset growth rate of Qingdao Haier Biomedical Co Ltd to track the company's year-over-year net asset growth rate.
Qingdao Haier Biomedical Co Ltd Capital Reinvestment Ratio by Year (2016–2025)
Qingdao Haier Biomedical Co Ltd capital reinvestment ratio by year from 2016 to 2025. For the full cash flow conversion analysis, see Qingdao Haier Biomedical Co Ltd (688139) cash flow conversion.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.45x | CN¥267.89 Million | CN¥119.25 Million | ▲ +2.5% |
| 2024 | 0.43x | CN¥291.67 Million | CN¥126.70 Million | ▼ -38.9% |
| 2023 | 0.71x | CN¥249.26 Million | CN¥177.18 Million | ▲ +52.8% |
| 2022 | 0.47x | CN¥632.43 Million | CN¥294.24 Million | ▲ +43.8% |
| 2021 | 0.32x | CN¥632.43 Million | CN¥204.69 Million | ▲ +153.4% |
| 2020 | 0.13x | CN¥696.62 Million | CN¥88.99 Million | ▼ -78.7% |
| 2019 | 0.60x | CN¥280.49 Million | CN¥168.40 Million | ▲ +29.0% |
| 2018 | 0.47x | CN¥149.00 Million | CN¥69.33 Million | ▲ +155.8% |
| 2017 | 0.18x | CN¥148.32 Million | CN¥26.98 Million | ▲ +176.8% |
| 2016 | 0.07x | CN¥220.72 Million | CN¥14.50 Million | — |